Does exercise raise MOTS-c?

Human data reports associations between exercise and measured levels. Association is the ceiling of what that evidence supports.

What is muscle-fat crosstalk?

Signalling molecules released by contracting muscle acting on adipose tissue — muscle behaving as a secretory organ.

Is it prohibited in sport?

Check the current WADA Prohibited List directly, as it is revised periodically and secondary sources go stale.

MOTS-c (Mitochondrial Peptide)

Why Exercise Keeps Appearing in This Literature

JMWritten & reviewed by Jack Muncaster · Founder, UK PeptidesLast reviewed 2026-08-233 cited sources

Skeletal muscle releases signalling molecules during contraction that act on other tissues including fat. Tero-Vescan and colleagues reviewed exercise-induced muscle-fat crosstalk in 2025, and Feng and colleagues reported on endurance training and mitochondrial respiration the same year.

Key facts

Concept: Muscle as a secretory organ
Crosstalk review: Tero-Vescan 2025 (PMID 40872612)
Training study: Feng 2025 (PMID 39706498)
Relevance: MOTS-c reported as exercise-responsive
Direction of inference: Correlation, in humans
Anti-doping: Check current WADA status

Muscle as a secretory tissue

Contracting skeletal muscle releases signalling molecules into circulation, and those act on distant tissues including adipose. This reframes exercise from a purely mechanical and energetic activity into an endocrine event, and it is the framework within which any exercise-responsive peptide is interpreted.

What the 2025 review covers

Tero-Vescan and colleagues published on exercise-induced muscle-fat crosstalk and the pharmacological modulation of its mediators in Pharmaceuticals in August 2025. The pharmacological framing is the notable part — it treats these mediators as potential intervention points rather than only as descriptive biology.

Research material referenced

MOTS-C 10mg — third-party HPLC tested

View — £24.99

The mitochondrial adaptation side

Feng and colleagues reported in Free Radical Biology and Medicine in February 2025 on endurance training enhancing skeletal muscle mitochondrial respiration. Training increases both mitochondrial number and their respiratory capacity, which is among the best-established adaptations in exercise physiology and is the substrate any mitochondrial signalling story sits on.

Why a mitochondrial peptide fits the picture

If mitochondria adapt to exercise and if they encode signalling peptides, a peptide released in proportion to mitochondrial activity would be a coherent way for muscle to report its metabolic state to the rest of the body. That is a mechanistically sensible hypothesis, and being sensible is not the same as being demonstrated.

The direction problem in the human data

Human observations here are associations between exercise and measured peptide levels. An association does not establish that the peptide causes the adaptation, that the adaptation causes the peptide, or that either is more than a marker of mitochondrial density. Correlation is the ceiling of what the current human evidence supports.

Anti-doping status

Anyone competing under an anti-doping code should check the current WADA Prohibited List directly rather than relying on any secondary source, including this one — the list is revised and status can change. Material supplied here is for laboratory research only and is not intended for use by any person.

Extended research context

The MOTS-c (Mitochondrial Peptide) deep dive

Deep dive: why a peptide encoded in mitochondrial DNA is unusual

The human mitochondrial genome is 16,569 base pairs encoding 37 genes, and was considered fully characterised by the 1980s: thirteen respiratory-chain proteins, twenty-two transfer RNAs, two ribosomal RNAs. MOTS-c is encoded by a short open reading frame nested inside the 12S rRNA gene — sequence already annotated as doing something else, which is exactly why it went unnoticed. Humanin, found in 2001 inside the 16S rRNA gene, established that the genome held more than its annotation suggested; MOTS-c was found in 2015 by looking deliberately. The implication is that the mitochondrion encodes and releases signalling molecules of its own, rather than only executing instructions sent from the nucleus.

Deep dive: AMPK activation without touching AMPK

AMPK is normally activated when AMP and ADP bind its gamma subunit, making it a direct sensor of the AMP-to-ATP ratio. MOTS-c does not raise that ratio and does not bind the kinase. It inhibits the folate cycle, the one-carbon pathway feeding de novo purine biosynthesis, and the intermediate AICAR accumulates as a result. AICAR is an AMP mimetic — phosphorylated to ZMP, it binds the same regulatory site AMP occupies. So the peptide reaches a cytosolic energy sensor through one-carbon metabolism and a diffusible small molecule, which is a materially different architecture from a receptor-ligand interaction, and different again from metformin's inhibition of complex I.

Deep dive: reading a preclinical literature honestly

Roughly 250 indexed papers exist, and the overwhelming majority are cell and rodent studies. Where humans appear, the work is generally observational: measuring circulating concentrations and correlating them with age, fitness or metabolic state. The 2021 Nature Communications paper is the clearest example of the structure — the human arm measured MOTS-c before and after exercise, finding roughly a 12-fold rise in skeletal muscle against 1.6-fold in circulation, while the interventional work was done in mice. Two inferences the secondary literature routinely makes and the primary literature does not support: that a correlation between low concentrations and poor metabolic health establishes direction, and that a molecule which rises during exercise would reproduce exercise if administered.

Research applications

▸Study of mitochondrial-derived peptides and retrograde signalling
▸AMPK pathway research through non-canonical activation
▸One-carbon and folate-cycle metabolism models
▸Exercise physiology and mitochondrial bioenergetics research
▸Ageing biology and mitochondrial genome expression studies

Handling checklist

✓Store lyophilised material cold, dry and protected from light
✓Expect methionine oxidation as the primary degradation route (+16 Da per residue)
✓No reducing agent needed — the sequence contains no cysteine
✓Introduce diluent gently against the vial wall; swirl rather than shake
✓Aliquot to avoid repeated freeze-thaw cycles
✓Check mass spectrometry for +16 and +32 satellites before relying on a batch

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Reading exercise induction as proof that administration mimics exercise

Fix: The papers report that exercise raises MOTS-c. The reverse inference is not supported and is not claimed.

✗ Treating human observational data as interventional evidence

Fix: Human work measures endogenous concentrations; administration studies were conducted in mice.

✗ Assuming MOTS-c has a cell-surface receptor like humanin

Fix: No receptor is established. Its characterised activity is intracellular.

✗ Storing reconstituted material as though it were as stable as the powder

Fix: Solution-phase material is subject to hydrolysis and oxidation; the lyophilised form is far more stable.

✗ Overlooking WADA status in athlete-adjacent research

Fix: MOTS-c is on the prohibited list; this is relevant to any research context involving competitors.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Frequently asked questions

Does exercise raise MOTS-c?: Human data reports associations between exercise and measured levels. Association is the ceiling of what that evidence supports.
What is muscle-fat crosstalk?: Signalling molecules released by contracting muscle acting on adipose tissue — muscle behaving as a secretory organ.
Is it prohibited in sport?: Check the current WADA Prohibited List directly, as it is revised periodically and secondary sources go stale.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Written and reviewed by

Jack Muncaster · Founder, UK Peptides

Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.

How we write and check this content Report a factual error in this article

More MOTS-c (Mitochondrial Peptide) articles

Popular across the research hub

One flagship guide from every other research category — keep exploring.

← Back to Forum